The Fourth INTERMACS Annual Report: 4,000 implants and counting.
The Fourth Annual Report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) summarizes and analyzes the first 5 years of patient and data collection. With more than 4,000 patients entered into the database, the evolution of pump technology, strategy at implant, and pre-implant patient profiles are chronicled. A risk factor analysis of the entire adult primary implant population is provided, and the recent composition of patient profiles is examined. Current actuarial survival with continuous-flow pumps exceeds 80% at 1 year and 70% at 2 years.
Division of Cardiovascular, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA. jkirklin@uab.edu
James K
JK
Kirklin
David C
DC
Naftel
Robert L
RL
Kormos
Lynne W
LW
Stevenson
Francis D
FD
Pagani
Marissa A
MA
Miller
J Timothy
JT
Baldwin
James B
JB
Young
D000847:Annual Reports as Topic; D005260:Female; D006333:Heart Failure / Q000401:mortality / Q000601:surgery; D016027:Heart Transplantation / Q000401:mortality / Q000706:statistics & numerical data; D006353:Heart-Assist Devices / Q000706:statistics & numerical data*; D006801:Humans; D007373:Interinstitutional Relations; D008297:Male; D008875:Middle Aged; D054555:National Heart, Lung, and Blood Institute (U.S.); D012042:Registries / Q000706:statistics & numerical data*; D012307:Risk Factors; D015996:Survival Rate; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration